Chengdu Kanghong Pharmaceutical Group
Establishment time : 1996
website : http://www.kanghong.com/
Main Product : Ophthalmic drugs, cardiovascular drugs, anti-infective drugs
Company Profile
Chengdu Kanghong Pharmaceutical Group is a renowned pharmaceutical company based in Chengdu, China. Established in 1996, the company specializes in the development, production, and marketing of a wide range of pharmaceutical products, with a focus on ophthalmic drugs, cardiovascular drugs, and anti-infective drugs. With a large workforce of over 10,000 employees, the company has a strong presence in China, Asia, Europe, and North America. Chengdu Kanghong Pharmaceutical Group is known for its commitment to innovation and research, making it a key player in the global pharmaceutical industry.
Hissen Biotech Co., Ltd.
Establishment time : 2005
website : www.hissenbiotech.com
Main Product : Biotechnology products, pharmaceuticals, medical devices
Company Profile
Hissen Biotech Co., Ltd. is a leading biotechnology company established in 2005. We specialize in the development and manufacturing of biotechnology products, pharmaceuticals, and medical devices. With a strong presence in the domestic market in China, we are now expanding into international markets. Our company is of medium size with over 100 employees dedicated to innovation and excellence in the biotech industry. Despite facing competition from both domestic and international companies, we strive to maintain our position as a key player in the biotech sector. Visit our website at www.hissenbiotech.com for more information.
Changchun BCHT Biotechnology Co., Ltd.
Establishment time : September 2013
website : http://www.bchtbio.com/
Main Product : Vaccines, biological products, diagnostic reagents
Company Profile
Changchun BCHT Biotechnology Co., Ltd. is a biotechnology company specializing in the development and production of vaccines, biological products, and diagnostic reagents. With a focus on innovation and quality, the company has established itself as a key player in the industry, serving markets in China, Southeast Asia, and the Middle East.
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
Establishment time : 1993
website : www.mingxingpharma.com
Main Product : Traditional Chinese medicine, pharmaceuticals, health products
Company Profile
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. is a leading pharmaceutical company specializing in the production of traditional Chinese medicine, pharmaceuticals, and health products. Established in 1993, the company has grown to become a major player in the industry with a large workforce of over 1000 employees. With a strong presence in China and expanding into international markets, Mingxing Pharmaceutical faces competition from both domestic and international pharmaceutical companies. The company is dedicated to providing high-quality and innovative products to meet the needs of customers worldwide.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Hualan Biological Engineering Inc.
Establishment time : Hualan Biological Engineering Inc. was founded in 1992 and has since become a leading biopharmaceutical company in China.
website :
Main Product : With a large company size, Hualan Biological Engineering Inc. has established a strong presence in the Chinese market as well as expanding to other markets in Asia and Africa.
Company Profile
Hualan Biological Engineering Inc. continues to strive for excellence in the biopharmaceutical industry and aims to make a positive impact on global health.
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Establishment time : 1992
website :
Main Product : Pharmaceutical products
Company Profile
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. was founded in 1992 and is a medium-sized pharmaceutical company based in Sichuan, China. They primarily focus on producing pharmaceutical products for the domestic market in China. The company faces strong competition from other pharmaceutical companies in China.
Shenzhen Weiguang Biological Products Co., Ltd.
Establishment time : Shenzhen Weiguang Biological Products Co., Ltd. was founded in 2004.
website :
Main Product : With a medium-sized operation, the company serves both domestic and international markets.
Company Profile
With a focus on customer satisfaction, the company strives to meet the needs of its clients.
April 27, 2024
